the quarterly will be an interesting read. I expect EXS to be rerated as the risk on money flows back in...(not there EXS is very risky anyway with $60M in the bank
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025